140 research outputs found

    Search for third generation vector-like leptons with the ATLAS detector

    Get PDF
    The Standard Model of particle physics provides a concise description of the building blocks of our universe in terms of fundamental particles and their interactions. It is an extremely successful theory, providing a plethora of predictions that precisely match experimental observation. In 2012, the Higgs boson was observed at CERN and was the last particle predicted by the Standard Model that had yet-to-be discovered. While this added further credibility to the theory, the Standard Model appears incomplete. Notably, it only accounts for 5% of the energy density of the universe (the rest being ``dark matter'' and ``dark energy''), it cannot resolve the gravitational force with quantum theory, it does not explain the origin of neutrino masses and cannot account for matter/anti-matter asymmetry. The most plausible explanation is that the theory is an approximation and new physics remains. Vector-like leptons are well-motivated by a number of theories that seek to provide closure on the Standard Model. They are a simple addition to the Standard Model and can help to resolve a number of discrepancies without disturbing precisely measured observables. This thesis presents a search for vector-like leptons that preferentially couple to tau leptons. The search was performed using proton-proton collision data from the Large Hadron Collider collected by the ATLAS experiment from 2015 to 2018 at center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of 139 inverse femtobarns. Final states of various lepton multiplicities were considered to isolate the vector-like lepton signal against Standard Model and instrumental background. The major backgrounds mimicking the signal are from WZ, ZZ, tt+Z production and from mis-identified leptons. A number of boosted decision trees were used to improve rejection power against background where the signal was measured using a binned-likelihood estimator. No excess relative to the Standard Model was observed. Exclusion limits were placed on vector-like leptons in the mass range of 130 to 898 GeV

    Simulation of Dark Bremsstrahlung in GEANT4

    Full text link
    A technique for the simulation of dark bremsstrahlung for electrons and muons in GEANT4 is presented. The total cross section is calculated using the Weizs\"{a}cker-Williams approximation and the outgoing kinematics are produced by scaling events produced in MadGraph/MadEvent to lower incident lepton energies, allowing the simulation to account for thick targets and lepton sources without fixed energies. The accuracy of the cross sections used and kinematics produced are discussed. Examples of its usage are presented for leptons in several thick target scenarios.Comment: 14 pages, 10 figure

    Exploring cancer health disparities among formerly incarcerated African Americans

    Get PDF
    Incarcerated populations have a higher burden of chronic disease and elevated risk factors for cancer (BJS, 2012). In 2013, cancer (31%) and heart disease (26%) accounted for over half of all prisoner deaths. The Genomics Research Program of the National Cancer Institute’s Division of Cancer Control and Population Sciences (2016) identified incarcerated persons as an understudied population about which there is limited data regarding cancer risks and outcomes. A majority of studies on corrections populations focus on health issues associated with reduction of infectious diseases such as HIV, Tuberculosis, and Hepatitis. Scant research has been conducted on issues associated with cancer prevention and control among African Americans with a history of incarceration. This qualitative, participatory, pilot research study explores the domains of cancer health disparities among African American men and women who were formerly incarcerated in Illinois prisons. Four qualitative focus groups will be conducted. The primary purpose of the focus groups is to collect and qualitatively analyze preliminary data on the barriers to access, utilization and treatment of cancer. This presentation seeks to: (1) describe the need for enhanced access to cancer care and treatment, (2) advocate for the inclusion of best practices in cancer care in corrections systems and, (3) identify policy recommendations and initiatives aimed at reducing cancer disparities among incarcerated and formerly incarcerated persons

    Photon-rejection Power of the Light Dark Matter eXperiment in an 8 GeV Beam

    Full text link
    The Light Dark Matter eXperiment (LDMX) is an electron-beam fixed-target experiment designed to achieve comprehensive model independent sensitivity to dark matter particles in the sub-GeV mass region. An upgrade to the LCLS-II accelerator will increase the beam energy available to LDMX from 4 to 8 GeV. Using detailed GEANT4-based simulations, we investigate the effect of the increased beam energy on the capabilities to separate signal and background, and demonstrate that the veto methodology developed for 4 GeV successfully rejects photon-induced backgrounds for at least 2×10142\times10^{14} electrons on target at 8 GeV.Comment: 28 pages, 20 figures; corrected author lis

    Drug use and needle sharing among adolescents and young adults in Nigeria: A cross-sectional secondary analysis of data from a multi-site clinical trial

    Get PDF
    Background: Adolescents and young adults (AYA, 14–24 years old) have the highest rates of drug use in most low- and middle-income countries. Little is known about the drivers of drug use among AYA in Nigeria and harm reduction services are limited. Methods: A secondary data analysis was performed of the baseline survey of the ‘I-TEST’ study involving AYA in Nigeria. The two primary outcomes of interest were lifetime measures of drug use and needle sharing. Logistic regression analyses were performed to obtain odds ratios for the associations between socio-demographic exposures and the two primary outcomes. Odds ratios were subsequently adjusted for age and sex. Results: 1500 AYA survey responses were analysed. Respondents were mostly unemployed, students, and living in southern Nigeria. Drug use was reported by 301/1500(20.3 %) AYA. Among these, 213/301(71.5 %) reported needle sharing. Drug use did not vary by age (OR:0.94, 95 %CI:0.73–1.22) or sex (OR:1.00, 95 %CI:0.77–1.28). AYA in the North-Central zone had higher odds of drug use (OR:1.86, 95 %CI:1.28–2.69) and needle sharing (OR:2.51, 95 %CI:1.07–5.91) compared to AYA in the South-West zone of Nigeria. AYA aged 14–19 had higher odds of needle sharing compared to those aged 20–24 (OR:3.49, 95 %CI:1.94–6.26). Female AYA had higher odds of needle sharing compared to males (OR:5.05, 95 %CI:2.85–8.95). Conclusions: Drug use and needle sharing are common among AYA in Nigeria. There is an urgent need for harm reduction services and research informed by AYA

    The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Get PDF
    Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

    Operation and performance of the ATLAS semiconductor tracker in LHC Run 2

    Get PDF
    The semiconductor tracker (SCT) is one of the tracking systems for charged particles in the ATLAS detector. It consists of 4088 silicon strip sensor modules. During Run 2 (2015–2018) the Large Hadron Collider delivered an integrated luminosity of 156 fb-1 to the ATLAS experiment at a centre-of-mass proton-proton collision energy of 13 TeV. The instantaneous luminosity and pile-up conditions were far in excess of those assumed in the original design of the SCT detector. Due to improvements to the data acquisition system, the SCT operated stably throughout Run 2. It was available for 99.9% of the integrated luminosity and achieved a data-quality efficiency of 99.85%. Detailed studies have been made of the leakage current in SCT modules and the evolution of the full depletion voltage, which are used to study the impact of radiation damage to the modules

    Swept Under the Rug? A Historiography of Gender and Black Colleges

    Full text link
    corecore